Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Mar-24 5:19 PM View:  | Neurocrine Biosciences Inc. (NBIX) | 13-Mar-24 | Option Exercise | 23,200 | $42.76 | $992,032.00 | 79% 29.51K to 52.71K | |
| 15-Mar-24 5:19 PM View: | Neurocrine Biosciences Inc. (NBIX) | 13-Mar-24 | Planned Option Sale | 23,200 | $140.33 | $3,255,620.00 | (44%) 52.71K to 29.51K | |
| 12-Mar-24 6:47 PM View: | Neurocrine Biosciences Inc. (NBIX) | 11-Mar-24 | Option Exercise | 100 | $42.76 | $4,276.00 | < 1% 29.51K to 29.61K | |
| 12-Mar-24 6:47 PM View: | Neurocrine Biosciences Inc. (NBIX) | 11-Mar-24 | Planned Option Sale | 100 | $140.00 | $14,000.00 | (< 1%) 29.61K to 29.51K | |
| 12-Mar-24 6:47 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Mar-24 | Option Exercise | 1,700 | $42.76 | $72,692.00 | 6% 29.51K to 31.21K | |
| 12-Mar-24 6:47 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Mar-24 | Planned Option Sale | 1,700 | $140.05 | $238,078.00 | (5%) 31.21K to 29.51K | |
| 22-Feb-24 5:11 PM View: | Neurocrine Biosciences Inc. (NBIX) | 20-Feb-24 | Option Exercise | 15,000 | $12.98 | $194,700.00 | 51% 29.51K to 44.51K | |
| 22-Feb-24 5:11 PM View: | Neurocrine Biosciences Inc. (NBIX) | 20-Feb-24 | Planned Option Sale | 15,000 | $132.47 | $1,987,050.00 | (34%) 44.51K to 29.51K | |
| 12-Feb-24 10:00 PM View: | Alkermes Plc. (ALKS) | 08-Feb-24 | Grant | 218,551 | -- | -- | 21% 1.05M to 1.27M | |
| 12-Feb-24 10:00 PM View: | Alkermes Plc. (ALKS) | 08-Feb-24 | Payment of Exercise | 91,757 | $26.77 | $2,456,340.00 | (7%) 1.27M to 1.18M | |
| 22-Feb-23 5:00 PM View: | Alkermes Plc. (ALKS) | 21-Feb-23 | Payment of Exercise | 14,386 | $27.77 | $399,499.00 | (1%) 1.07M to 1.05M | |
| 22-Feb-23 5:00 PM View: | Alkermes Plc. (ALKS) | 21-Feb-23 | Option Exercise | 32,400 | -- | -- | 3% 1.03M to 1.07M | |
| 22-Feb-23 5:00 PM View: | Alkermes Plc. (ALKS) | 20-Feb-23 | Grant | 119,713 | -- | -- | 12% 968.3K to 1.09M | |
| 22-Feb-23 5:00 PM View: | Alkermes Plc. (ALKS) | 20-Feb-23 | Payment of Exercise | 53,145 | $28.07 | $1,491,780.00 | (5%) 1.09M to 1.03M | |
| 05-Jan-23 6:18 PM View: | Neurocrine Biosciences Inc. (NBIX) | 03-Jan-23 | Option Exercise | 15,000 | $12.71 | $190,650.00 | 51% 29.51K to 44.51K | |
| 05-Jan-23 6:18 PM View: | Neurocrine Biosciences Inc. (NBIX) | 03-Jan-23 | Planned Option Sale | 15,000 | $119.20 | $1,788,040.00 | (34%) 44.51K to 29.51K | |
| 11-May-22 5:36 PM View: | Neurocrine Biosciences Inc. (NBIX) | 09-May-22 | Option Exercise | 15,000 | $6.66 | $99,900.00 | 51% 29.51K to 44.51K | |
| 11-May-22 5:36 PM View: | Neurocrine Biosciences Inc. (NBIX) | 09-May-22 | Planned Option Sale | 15,000 | $76.30 | $1,144,460.00 | (34%) 44.51K to 29.51K | |
| 06-May-22 5:04 PM View: | Alkermes Plc. (ALKS) | 06-May-22 | Option Exercise | 120,847 | $16.55 | $2,000,020.00 | 13% 941.2K to 1.06M | |
| 06-May-22 5:04 PM View: | Alkermes Plc. (ALKS) | 06-May-22 | Option Sale | 93,747 | $27.85 | $2,611,310.00 | (9%) 1.06M to 968.3K | |
| 06-May-22 5:04 PM View: | Alkermes Plc. (ALKS) | 05-May-22 | Option Exercise | 329,153 | $16.55 | $5,447,480.00 | 38% 865.56K to 1.19M | |
| 06-May-22 5:04 PM View: | Alkermes Plc. (ALKS) | 05-May-22 | Option Sale | 253,510 | $28.03 | $7,106,470.00 | (21%) 1.19M to 941.2K | |
| 23-Feb-22 4:37 PM View: | Alkermes Plc. (ALKS) | 21-Feb-22 | Payment of Exercise | 14,386 | $25.08 | $360,801.00 | (2%) 879.94K to 865.56K | |
| 23-Feb-22 4:37 PM View: | Alkermes Plc. (ALKS) | 21-Feb-22 | Option Exercise | 32,400 | -- | -- | 4% 847.54K to 879.94K | |
| 17-Feb-22 4:21 PM View: | Alkermes Plc. (ALKS) | 16-Feb-22 | Payment of Exercise | 8,038 | $26.79 | $215,338.00 | (< 1%) 855.58K to 847.54K | |
| 17-Feb-22 4:21 PM View: | Alkermes Plc. (ALKS) | 16-Feb-22 | Option Exercise | 18,125 | -- | -- | 2% 837.46K to 855.58K | |
| 19-May-21 4:27 PM View: | Alkermes Plc. (ALKS) | 18-May-21 | Option Exercise | 150,000 | $18.10 | $2,715,750.00 | 19% 792.04K to 942.04K | |
| 19-May-21 4:27 PM View: | Alkermes Plc. (ALKS) | 18-May-21 | Market Option Sale (Planned) | 150,000 | $21.90 | $3,285,400.00 | (16%) 942.04K to 792.04K | |
| 12-May-21 4:24 PM View: | Alkermes Plc. (ALKS) | 11-May-21 | Option Exercise | 150,000 | $18.10 | $2,715,750.00 | 19% 792.04K to 942.04K | |
| 12-May-21 4:24 PM View: | Alkermes Plc. (ALKS) | 11-May-21 | Market Option Sale (Planned) | 150,000 | $22.09 | $3,313,340.00 | (16%) 942.04K to 792.04K | |
| 07-May-21 4:47 PM View: | Alkermes Plc. (ALKS) | 06-May-21 | Option Exercise | 100,000 | $18.10 | $1,810,500.00 | 13% 792.04K to 892.04K | |
| 07-May-21 4:47 PM View: | Alkermes Plc. (ALKS) | 06-May-21 | Market Option Sale (Planned) | 100,000 | $21.79 | $2,179,410.00 | (11%) 892.04K to 792.04K | |
| 23-Feb-21 9:37 PM View: | Alkermes Plc. (ALKS) | 21-Feb-21 | Payment of Exercise | 14,386 | $19.58 | $281,678.00 | (2%) 806.43K to 792.04K | |
| 23-Feb-21 9:37 PM View: | Alkermes Plc. (ALKS) | 21-Feb-21 | Option Exercise | 32,400 | -- | -- | 4% 774.03K to 806.43K | |
| 18-Feb-21 7:28 PM View: | Alkermes Plc. (ALKS) | 17-Feb-21 | Payment of Exercise | 3,869 | $19.97 | $77,263.90 | (< 1%) 777.89K to 774.03K | |
| 18-Feb-21 7:28 PM View: | Alkermes Plc. (ALKS) | 17-Feb-21 | Option Exercise | 8,750 | -- | -- | 1% 769.14K to 777.89K | |
| 18-Feb-21 7:28 PM View: | Alkermes Plc. (ALKS) | 16-Feb-21 | Payment of Exercise | 8,074 | $19.79 | $159,784.00 | (1%) 777.22K to 769.14K | |
| 18-Feb-21 7:28 PM View: | Alkermes Plc. (ALKS) | 16-Feb-21 | Option Exercise | 18,125 | -- | -- | 2% 759.09K to 777.22K | |
| 14-May-20 5:00 PM View: | Alkermes Plc. (ALKS) | 14-May-20 | Option Exercise | 75,000 | $11.74 | $880,500.00 | 10% 759.09K to 834.09K | |
| 14-May-20 5:00 PM View: | Alkermes Plc. (ALKS) | 14-May-20 | Market Option Sale (Planned) | 75,000 | $15.00 | $1,125,230.00 | (9%) 834.09K to 759.09K | (43%) |
| 07-May-20 4:26 PM View: | Alkermes Plc. (ALKS) | 07-May-20 | Option Exercise | 50,000 | $11.74 | $587,000.00 | 7% 759.09K to 809.09K | |
| 07-May-20 4:26 PM View: | Alkermes Plc. (ALKS) | 07-May-20 | Market Option Sale (Planned) | 50,000 | $14.63 | $731,265.00 | (6%) 809.09K to 759.09K | (47%) |
| 03-Apr-20 4:22 PM View: | Alkermes Plc. (ALKS) | 02-Apr-20 | Option Exercise | 50,000 | $11.74 | $587,000.00 | 7% 759.09K to 809.09K | |
| 03-Apr-20 4:22 PM View: | Alkermes Plc. (ALKS) | 02-Apr-20 | Market Option Sale (Planned) | 50,000 | $13.79 | $689,500.00 | (6%) 809.09K to 759.09K | (56%) |
| 26-Mar-20 4:38 PM View: | Alkermes Plc. (ALKS) | 26-Mar-20 | Option Exercise | 75,000 | $11.74 | $880,500.00 | 10% 759.09K to 834.09K | |
| 26-Mar-20 4:38 PM View: | Alkermes Plc. (ALKS) | 26-Mar-20 | Market Option Sale (Planned) | 75,000 | $14.36 | $1,077,220.00 | (9%) 834.09K to 759.09K | (50%) |
| 19-Mar-20 4:10 PM View: | Alkermes Plc. (ALKS) | 19-Mar-20 | Option Exercise | 75,000 | $11.74 | $880,500.00 | 10% 759.09K to 834.09K | |
| 19-Mar-20 4:10 PM View: | Alkermes Plc. (ALKS) | 19-Mar-20 | Market Option Sale (Planned) | 75,000 | $14.47 | $1,085,430.00 | (9%) 834.09K to 759.09K | (49%) |
| 03-Mar-20 4:36 PM View: | Alkermes Plc. (ALKS) | 01-Mar-20 | Payment of Exercise | 7,770 | $20.84 | $161,927.00 | (1%) 766.86K to 759.09K | (3%) |
| 03-Mar-20 4:36 PM View: | Alkermes Plc. (ALKS) | 01-Mar-20 | Option Exercise | 17,500 | -- | -- | 2% 749.36K to 766.86K |